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Purpose or Objective: IMRT is the standard of care in the 
treatment of H&N carcinoma based on level 1 evidence. 
However, today there is a greater chance of missing the 
tumor due to uncertainties in target volume definition by the 
clinician that is demanded by the highly conformal planning 
process involved with IMRT. The aim of this work is to 
compare the outcome in 3D and IMRT treatments in our first 
two years using IMRT. 
 
Material and Methods: From January 2011 to December 
2014, 152 head and neck cancer patients were treated with 
adjuvant or radical radiotherapy at the Fundacion Jimenez 
Diaz Radiation Oncology Department. Patients received 
standard treatments with surgery and chemotherapy 
following international guidelines. Most of them were locally 
advanced cancer patients with extensive fields of treatment 
and high doses of radiotherapy. We have analyzed 
retrospectively the outcome of these patients regarding 
local/regional control. Data from technique of treatment 
employed (3D/IMRT), failure location (infield/outfield) and 
time to failure (persistence/early recurrence or before 6 
months/late recurrence or after 6 months) were collected 
and compared with spss tools. Employed technique depended 
on the year and the availability. Our department started 
IMRT techniques in March 2013. 
 
Results: In this group of 152 patients, 30 (19%) recurrences 
were found: 21 (20%) in the group treated with 3D techniques 
(101 patients) and 9 (17%) in the group treated with IMRT (51 
patients). 21 recurrences were in field, 2 of them in the 
elective nodal radiation field. Seven (23%) of the recurrences 
infield were included the IMRT group, and 21 (66%) in the 3D 
group. Tumor persistence was identified in 6 (20%) patients 
treated with 3D and 4 (13%) with IMRT. Recurrences outfield 
were similar in both techniques, lightly higher in the IMRT 
group (28% vs 33%). However, this data has no relevance 
keeping in mind he number of patients in each group. In the 
3D group there were found 6 patients with early recurrence 
(before 6 months) and no patients in the IMRT group. 
 
Conclusion: In this group, recurrences were mostly infield, 
regardless of the employed technique. These data confirm 
conclusions previously published in large series with 3D 
radiotherapy. The IMRT group showed lower treatment 
failures and no early recurrences. However, it is needed to go 
on checking the IMRT implementation in the departments: to 
review possible uncertainties in target volume, to define the 
target with the best image techniques and to assess 
retrospectively the outcome. 
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Purpose or Objective: To determine the impact of CT-
determined pretreatment primary tumor volume on the 
overall survival (OS) in T4a laryngeal squamous cell 
carcinoma (LSCC) patients. 
 
Material and Methods: We retrospectively reviewed patients 
with proved diagnosis of T4a (AJCC 7th) LSCC from 1983 to 
2011 at MD Anderson Cancer Center under an approved IRB 
protocol. Primary tumors were manually contoured on 
pretreatment diagnostic CT scans for all patients with 
available scans then total tumor volumes were recorded. Cox 
regression multivariate analysis was done to investigate the 
impact of the following variables (age, sex, ethnicity, LSCC 
subsite of origin, performance status, nodal stage, surgical 
treatment, radiation use and dose, chemotherapy use, and 
tumor volume) on OS. Recursive partitioning analysis (RPA) 
was used to determine cut point of tumor volume associated 
with OS then Kaplan-Meier curves were plotted for groups 
above and below the RPA-derided cut point and log-rank tests 
was used to compare OS in both groups. 
 
Results: A total of 124 patients were included. Median 
follow-up was 68 months, and median age at the time of 
diagnosis was 58 years. Table 1 summarizes patients, disease, 
and treatment characteristics. 
 
 
 
A total of 83 patients (67%) received total laryngectomy 
followed by postoperative radiotherapy (TL-PORT), and 41 
patients (33%) received larynx preservation (LP) with 
radiotherapy (RT). The distribution of sex was 101 males 
(81%) and 23 females (19%). On multivariate analysis, the 
only independent predictor of OS was tumor volume (HR 2.6; 
95% CI 1.5-4.5, p=0.0006). RPA derived the cutpoint at 21cc. 
Patients with tumors ≥ 21cc had significantly worse 5-year OS 
compared to <21cc (44% vs. 64%, p=0.003) as in Figure 1. 
 
 
 
Conclusion: Our results suggest that pretreatment primary 
tumor volume was the only independent predictor of OS in 
T4a LSCC patients. We recommend the routine measurement 
